ESC Premium Access

Riociguat in transthyretin cardiac amyloidosis-data from a named patient use program in austria

Topic: Cardiovascular Pharmacotherapy, Other

Congress Session

About the speaker

Doctor Franz Duca

Medical University of Vienna, Vienna (Austria)
0 follower

7 more presentations in this session

The monocentric, double-blind, placebo-controlled research of sildenafil impact in pediatric patients with secondary pulmonary hypertension.

Speaker: Associate Professor I. Palii (Chisinau, MD)

Thumbnail

Obesity paradox outcomes after acute myocardial infarction in Japanese is due to optimal medical therapy in overweight patients

Speaker: Assistant Professor K. Sakamoto (Kumamoto, JP)

Thumbnail

Elucidating the underlying mechanisms for the differential response to sodium channel blocker antiarrhythmic drugs in obese patients with atrial fibrillation

Speaker: Assistant Professor M. Mccauley (Chicago, US)

Thumbnail

The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

Speaker: Doctor T. Abe (Tokyo, JP)

Thumbnail

Polymorphism RS776746 in the gene of CYP3A5 as a possible predictor of clinical efficiency of bisoprolol in patients transplanted with acute coronary syndrome

Speaker: Doctor V. Shumkov (Saint Petersburg, RU)

Thumbnail

Access the full session

Cardiovascular drug therapy in special populations

Speakers: Doctor F. Duca, Associate Professor I. Palii, Assistant Professor K. Sakamoto, Assistant Professor M. Mccauley, Doctor T. Abe...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk